Matthew P. Smith concentrates his practice on complex products liability cases, primarily involving pharmaceutical products and medical devices.
Matt has substantial experience in complex pharmaceutical actions in both state and federal courts nationwide. He defends manufacturers in cases involving over-the-counter medications, prescription drugs, medical devices, and other products, and has significant involvement with all stages and aspects of cases, including discovery, expert witnesses, trial preparation, and trial.

Representative matters:

Representation of medical device company in state and federal litigation involving claims of injuries from pelvic mesh, including serving as trial counsel in a 7-day jury trial that resulted in a defense verdict in March 2022 (see “Johnson and Johnson Wins Third Ethicon Pelvic Mesh Trial This Year,” Law.com, July 6, 2022).
Representation of pharmaceutical company in state and federal litigation involving claims of Stevens-Johnson Syndrome and/or Toxic Epidermal Necrolysis from an over-the-counter medication, including serving on the trial team for more than 10 jury trials.
Representation of pharmaceutical company in thousands of suits in a state coordinated litigation involving claims of gynecomastia and other alleged injuries from a prescription medication.
Representation of medical device company in state and federal litigation involving claims of injury from use of sutures.
Representation of company and laboratory in suits alleging HIV and hepatitis exposure from reuse of needles during phlebotomy procedures.
Representation of company in litigation involving claims of chemical burns from tagless labels in baby clothing.

Distinctions

Super Lawyers®
- California, Personal Injury: Products, Rising Stars, 2013-2018

Bar Admissions

Co-Author, “FDA Streamlines 510(k) Process, As Courts Reconsider It,” Law 360, November 2018.
Author, “Tragic, but Is It a Wrongful Death? Tips for Defending a Suicide Case,” The Brief (American Bar Association), Spring 2015.

P (615) 651-6796

F (615) 651-6701

Matt practices within Butler Snow's Pharmaceutical, Medical Device and Healthcare Group.

Matthew P. Smith concentrates his practice on complex products liability cases, primarily involving pharmaceutical products and medical devices.
Matt has substantial experience in complex pharmaceutical actions in both state and federal courts nationwide. He defends manufacturers in cases involving over-the-counter medications, prescription drugs, medical devices, and other products, and has significant involvement with all stages and aspects of cases, including discovery, expert witnesses, trial preparation, and trial.

Representative matters:

Representation of medical device company in state and federal litigation involving claims of injuries from pelvic mesh, including serving as trial counsel in a 7-day jury trial that resulted in a defense verdict in March 2022 (see “Johnson and Johnson Wins Third Ethicon Pelvic Mesh Trial This Year,” Law.com, July 6, 2022).
Representation of pharmaceutical company in state and federal litigation involving claims of Stevens-Johnson Syndrome and/or Toxic Epidermal Necrolysis from an over-the-counter medication, including serving on the trial team for more than 10 jury trials.
Representation of pharmaceutical company in thousands of suits in a state coordinated litigation involving claims of gynecomastia and other alleged injuries from a prescription medication.
Representation of medical device company in state and federal litigation involving claims of injury from use of sutures.
Representation of company and laboratory in suits alleging HIV and hepatitis exposure from reuse of needles during phlebotomy procedures.
Representation of company in litigation involving claims of chemical burns from tagless labels in baby clothing.

Super Lawyers®
- California, Personal Injury: Products, Rising Stars, 2013-2018

Co-Author, “FDA Streamlines 510(k) Process, As Courts Reconsider It,” Law 360, November 2018.
Author, “Tragic, but Is It a Wrongful Death? Tips for Defending a Suicide Case,” The Brief (American Bar Association), Spring 2015.